版本:
中国

BRIEF-Merrimack stockholders approve Onivyde, generic Doxil sale to Ipsen

March 30 Merrimack Pharmaceuticals Inc:

* Merrimack stockholders approve sale of Onivyde and generic version of Doxil to Ipsen for up to $1.025 billion

* Expects transaction to be completed in coming days Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐